human embryonic stem cells

Clinical embryonic stem cell trials are set to begin in China, according to Nature News.

The collaboration between Columbia University and The Hebrew University suggests some surprising biology could improve loss-of-function genetic screening.

In Nucleic Acids Research this week: literature-mining method for uncovering additional gene-disease associations, database of human embryonic stem cell and induced pluripotent stem cell lines, and more.

NEW YORK (GenomeWeb) – Cellectis today announced it is selling its stem cell-focused subsidiary Cellectis AB to Takara Bio for an undisclosed amount.

NEW YORK (GenomeWeb News) – The National Institutes of Health Stem Cell Registry has approved 52 human embryonic stem cell lines from Genea Biocells, the Australian company said this week.

NEW YORK (GenomeWeb News) – Public interest groups Consumer Watchdog and the Public Patent Foundation said Tuesday that they have asked a federal appeals court to invalidate a patent held by the Wisconsin Alumni Research Foundation covering human embryonic stem cells.

Life Technologies this week announced the commercial availability of a pair of new PCR-related products for molecular biology research.

NEW YORK (GenomeWeb News) – A new study suggests a significant proportion of long, non-coding RNAs, or lncRNAs, are transcribed in cahoots with neighboring messenger RNAs in mammalian stem cells.

By Ben Butkus
Stanford University researchers have published a method for using Fluidigm's digital PCR platform to conduct single-cell, real-time PCR to compare gene expression patterns of single cells.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.